Japan’s digital therapeutics (DTx) market is expected to rapidly grow, presenting opportunities for U.S. DTx companies.

Malaysia’s $1B nutritional supplement market by 2030 offers growing opportunities for U.S. companies amid rising health awareness and aging trends.

To market a medical device in Egypt, manufacturers must register their products with the Egyptian Drug Authority (EDA). 

India’s commitment to improve patient lives through automation in surgery presents opportunities for U.S. companies.

For U.S. companies, this market dynamic presents a timely and strategic opportunity to provide solutions across a wide spectrum of healthcare needs

The German telehealth market is growing due to aging population and an growing need for medical services, alongside a push for digitalization from Government.

South Korea’s $4.7B health supplement market ($20B by 2030) offers strong potential for U.S. firms, but regulatory compliance is critical.

Austria pharmaceuticals

Malaysia’s surgical robotics market growth, fueled by tech innovation, aging population, and medical tourism, offering strong opportunities for U.S. companies.

Slovakia’s focus on healthcare readiness is opening new avenues for U.S. businesses in healthcare IT, telemedicine, cybersecurity, medical equipment, and more.

Kuwait’s healthcare sector offers opportunities to U.S. rehabilitation service providers

The European Commission has taken action in the past several weeks to tackle the PRC’s unfair market practices

India’s $12B MedTech market is set to hit $50B by 2030, offering big opportunities for U.S. firms—despite regulatory, pricing, and IP challenges.

Peru’s Law 32319 allows expedited registration of pharmaceuticals from countries with strong health monitoring, giving U.S. exporters quicker market access. 

 The new Ghanaian Government has announced initiatives to reform Ghana’s healthcare system, including a trust fund aimed at bridging healthcare financing.